Sai Parenteral's Share Price
487.30+3.40 (+0.70%)
+20.11% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SAIPARENTNSE
Sai Parenteral's Share Price
487.30+3.40 (+0.70%)
+20.11% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 58% | 134% |
| - | - | 56% | -1% |
| - | - | - | - |
| 13% | 13% | 13% | 5% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
LAURUSLABS
CIPLA
DRREDDY
MANKIND
AUROPHARMA
LUPIN
SAIPARENT
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,758.8 | ₹422427 Cr | 34.92 | 12.07 | 62.82 | ₹11479 Cr |
| 9,144.5 | ₹239982 Cr | 82.05 | 34.04 | 128.41 | ₹2568 Cr |
| 4,558.9 | ₹175196 Cr | 80.33 | 16.72 | 97.06 | ₹2163 Cr |
| 1,123 | ₹113790 Cr | 25.21 | 9.42 | 62.53 | ₹5040 Cr |
| 2,060.1 | ₹109143 Cr | 99.82 | 6.8 | 29.25 | ₹889 Cr |
| 1,325.1 | ₹107746 Cr | 31.97 | 9.77 | 57.87 | ₹3879 Cr |
| 1,233 | ₹101894 Cr | 31.62 | 5.32 | 63.99 | ₹4196 Cr |
| 2,275.5 | ₹97264 Cr | 47.62 | 13.75 | 71.08 | ₹1913 Cr |
| 1,666.9 | ₹96376 Cr | 25.96 | 17.95 | 96.84 | ₹3505 Cr |
| 1,961.6 | ₹89592 Cr | 16.2 | 30.95 | 154.35 | ₹5333 Cr |
| 487.5 | ₹2138 Cr | 129.53 | 1.79 | 7.55 | ₹17 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Jun 2025 |
|---|---|---|
| ₹179 Cr | ₹198 Cr | ₹33 Cr |
| ₹4 Cr | ₹3 Cr | ₹1 Cr |
| ₹182 Cr | ₹201 Cr | ₹35 Cr |
| ₹163 Cr | ₹180 Cr | ₹30 Cr |
| ₹27 Cr | ₹29 Cr | ₹6 Cr |
| ₹9 Cr | ₹8 Cr | ₹2 Cr |
| ₹10 Cr | ₹12 Cr | ₹2 Cr |
| ₹8 Cr | ₹13 Cr | ₹1 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| — | — | — | — |
| ₹22 Cr | ₹13 Cr | ₹13 Cr | ₹7 Cr |
| ₹469 Cr | ₹80 Cr | ₹61 Cr | ₹24 Cr |
| ₹469 Cr | ₹80 Cr | ₹61 Cr | ₹24 Cr |
| ₹491 Cr | ₹94 Cr | ₹75 Cr | ₹31 Cr |
| ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹0 |
| ₹80 Cr | ₹12 Cr | ₹36 Cr | ₹26 Cr |
| ₹11 Cr | ₹2 Cr | ₹3 Cr | ₹0 |
| -₹8 Cr | -₹52 L | -₹65 L | ₹13 L |
| ₹265 Cr | ₹0 | ₹0 | ₹0 |
| ₹75 L | ₹50 L | ₹21 L | ₹8 L |
| ₹348 Cr | ₹14 Cr | ₹38 Cr | ₹26 Cr |
| — | — | — | — |
| ₹149 Cr | ₹58 Cr | ₹53 Cr | ₹22 Cr |
| ₹165 Cr | ₹17 Cr | ₹17 Cr | ₹13 Cr |
| ₹223 Cr | ₹73 Cr | ₹71 Cr | ₹35 Cr |
| ₹36 Cr | ₹14 Cr | ₹12 Cr | ₹7 Cr |
| ₹573 Cr | ₹162 Cr | ₹153 Cr | ₹77 Cr |
| ₹1416 Cr | ₹272 Cr | ₹267 Cr | ₹134 Cr |
| ₹6 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr |
| ₹319 Cr | ₹94 Cr | ₹119 Cr | ₹69 Cr |
| — | — | — | — |
| ₹432 Cr | ₹79 Cr | ₹99 Cr | ₹55 Cr |
| ₹68 Cr | ₹26 Cr | ₹29 Cr | ₹11 Cr |
| ₹364 Cr | ₹53 Cr | ₹70 Cr | ₹44 Cr |
| ₹212 Cr | ₹50 L | ₹0 | ₹2 Cr |
| ₹16 Cr | ₹17 Cr | ₹9 Cr | ₹5 Cr |
| ₹2 Cr | ₹1 Cr | ₹61 L | ₹92 L |
| ₹594 Cr | ₹72 Cr | ₹80 Cr | ₹52 Cr |
| — | — | — | — |
| ₹172 Cr | ₹51 Cr | ₹37 Cr | ₹13 Cr |
| ₹181 Cr | ₹127 Cr | ₹127 Cr | ₹61 Cr |
| ₹417 Cr | ₹2 Cr | ₹4 Cr | ₹17 L |
| ₹18 Cr | ₹4 Cr | ₹2 Cr | ₹87 L |
| ₹34 Cr | ₹16 Cr | ₹16 Cr | ₹7 Cr |
| ₹822 Cr | ₹200 Cr | ₹187 Cr | ₹82 Cr |
| ₹249 Cr | ₹38 Cr | ₹35 Cr | ₹5 Cr |
| ₹1416 Cr | ₹272 Cr | ₹267 Cr | ₹134 Cr |
| ₹111 | ₹35 | ₹56 | ₹44 |
| ₹111 | ₹35 | ₹28 | ₹22 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ₹12 Cr | ₹20 Cr | ₹13 Cr | ₹7 Cr |
| ₹31 Cr | ₹20 Cr | ₹21 Cr | ₹12 Cr |
| ₹56 Cr | -₹7 Cr | -₹63 Cr | -₹29 Cr |
| ₹98 Cr | ₹34 Cr | -₹30 Cr | -₹10 Cr |
| ₹93 Cr | ₹33 Cr | -₹30 Cr | -₹13 Cr |
| -₹274 Cr | ₹44 L | -₹46 Cr | -₹19 Cr |
| ₹596 Cr | -₹36 Cr | ₹79 Cr | ₹24 Cr |
| ₹415 Cr | -₹2 Cr | ₹2 Cr | -₹8 Cr |
| ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹10 Cr |
| ₹417 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Sai Parenteral's Share Price
487.30+3.40 (+0.70%)
+20.11% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 oscillators
RSI
40.33Sell
STOCH %K
10.84Buy
MACD Level(12,26)
-8.43Sell
Ultimate Oscillator
40.00Sell
Aroon Oscillator
-26.00Sell
BOP
0.29Buy
CCI
-168.99Buy
Williams %R
-89.16Buy
Momentum
-16.65Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 7 out of 9 moving averages
EMA 9
497.32Sell
SMA 9
500.88Sell
EMA 21
505.61Sell
SMA 21
506.20Sell
EMA 50
517.81Sell
SMA 50
523.01Sell
EMA 200
0.00Neutral
SMA 200
0.00Neutral
WMA 20
502.80Sell
Pivot
Pivot
Classic
Resistance 5
560.63
Resistance 4
542.63
Resistance 3
524.63
Resistance 2
506.63
Resistance 1
495.27
Pivot
488.63
Support 1
477.27
Support 2
470.63
Support 3
452.63
Support 4
434.63
Support 5
416.63
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Sai Parenteral's Share Price
487.30+3.40 (+0.70%)
+20.11% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 |
|---|---|
| 51.16% | 51.16% |
| 4.03% | 5.73% |
| 7.54% | 9.05% |
| 0.98% | 3.81% |
| 36.29% | 30.25% |
Bulk & block deals
Name
Hrti Private Limited
Hrti Private Limited
Arihant Capital Markets Limited
Bhaskara Rao Bollineni
Arihant Capital Markets Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 02 Jul 2026 | Purchase | 6.74 Cr | ₹639.68 | 1.05 L | Bulk | 0.238556 | NSE |
| 02 Jul 2026 | Sell | 14.47 Cr | ₹637.95 | 2.27 L | Bulk | 0.513441 | NSE |
| 09 Apr 2026 | Purchase | 16.84 Cr | ₹423.13 | 3.98 L | Bulk | 0.900892 | NSE |
| 07 Apr 2026 | Purchase | 20.96 Cr | ₹409.25 | 5.12 L | Bulk | 1.159462 | NSE |
| 02 Apr 2026 | Purchase | 18.39 Cr | ₹407.60 | 4.51 L | Bulk | 1.021322 | BSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Sai Parenteral's Share Price
487.30+3.40 (+0.70%)
+20.11% past 1 Year
Sai Parenteral’s, along with its subsidiaries, carries out contract research and manufacturing activities for customers engaged in pharmaceutical industries. Its portfolio includes formulation products across various therapeutic areas like cardiovascular,
Corporate Actions
Date
Type
Details
Company details
Sai Parenteral's Share Price
487.30+3.40 (+0.70%)
+20.11% past 1 Year
Corporate filings & documents
Announcements
Annual reports
No annual reports found
Concalls & investor presentations
Sai Parenteral's Share Price
487.30+3.40 (+0.70%)
+20.11% past 1 Year
News
Sai Parenterals Acquires Majority Stake In Hyderabad Research Facility
Equity
SAIPARENT
Sai Parenterals unit Noumed extends Australian OTC pharmacy supply agreement
Equity
SAIPARENT
Sai Parenterals schedules analyst and investor meet on July 3 at 4.30 PM
Equity
SAIPARENT
Sai Parenterals to hold analyst and investor meet on July 2, 2026
Equity
SAIPARENT
Sai Parenterals secures 10-year supply order worth Rs 104.50 crore
Equity
SAIPARENT
Sai Parenterals outlines FY27 manufacturing and product pipeline expansion targets
Equity
SAIPARENT
Sai Parenterals unveils multi-year FY27 capex plan to scale injectables and CDMO exports
Equity
SAIPARENT
Sai Parenterals outlines Rs 440 crores capex plan targeted for completion by FY27
Equity
SAIPARENT
Sai Parenterals sets ambitious FY27 revenue and EBITDA margin targets
Equity
SAIPARENT
Sai Parenterals debuts at 3% premium on the BSE
Equity
SAIPARENT
Sai Parenterals Shares List at Rs 405 on BSE After Issue Price of Rs 392.
Equity
SAIPARENT